Protagonist Therapeutics, Inc. (PTGX)
154.70
+0.38
(+0.25%)
USD |
NASDAQ |
Aug 24, 16:00
154.70
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Total Liabilities (Quarterly) : 44.00M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 44.00M |
| March 31, 2026 | 41.99M |
| December 31, 2025 | 55.19M |
| September 30, 2025 | 56.25M |
| June 30, 2025 | 49.99M |
| March 31, 2025 | 53.08M |
| December 31, 2024 | 71.54M |
| September 30, 2024 | 71.94M |
| June 30, 2024 | 73.30M |
| March 31, 2024 | 68.83M |
| December 31, 2023 | 21.50M |
| September 30, 2023 | 27.87M |
| June 30, 2023 | 26.40M |
| March 31, 2023 | 23.69M |
| December 31, 2022 | 32.32M |
| September 30, 2022 | 38.56M |
| June 30, 2022 | 42.53M |
| March 31, 2022 | 46.52M |
| December 31, 2021 | 47.67M |
| September 30, 2021 | 43.52M |
| June 30, 2021 | 46.78M |
| Date | Value |
|---|---|
| March 31, 2021 | 38.74M |
| December 31, 2020 | 45.90M |
| September 30, 2020 | 47.73M |
| June 30, 2020 | 57.50M |
| March 31, 2020 | 72.24M |
| December 31, 2019 | 76.22M |
| September 30, 2019 | 59.27M |
| June 30, 2019 | 63.79M |
| March 31, 2019 | 31.42M |
| December 31, 2018 | 26.96M |
| September 30, 2018 | 24.90M |
| June 30, 2018 | 29.81M |
| March 31, 2018 | 34.62M |
| December 31, 2017 | 43.10M |
| September 30, 2017 | 52.58M |
| June 30, 2017 | 9.449M |
| March 31, 2017 | 7.779M |
| December 31, 2016 | 6.435M |
| September 30, 2016 | 5.349M |
| June 30, 2016 | 4.11M |
| March 31, 2016 | 5.475M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.62B |
| Insmed, Inc. | 1.345B |
| Madrigal Pharmaceuticals, Inc. | 720.92M |
| AbbVie, Inc. | 141.00B |
| PTC Therapeutics, Inc. | 3.416B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 885.54M |
| Shareholders Equity (Quarterly) | 841.54M |
| Debt to Equity Ratio | 0.011 |
| Current Ratio | 21.71 |
| Net Debt Paydown Yield | 0.01% |